KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rigel Pharmaceuticals (RIGL) Change in Acquisitions & Divestments (2016 - 2025)

Historic Change in Acquisitions & Divestments for Rigel Pharmaceuticals (RIGL) over the last 17 years, with Q3 2025 value amounting to $20.7 million.

  • Rigel Pharmaceuticals' Change in Acquisitions & Divestments rose 24550.0% to $20.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $54.3 million, marking a year-over-year increase of 3948.65%. This contributed to the annual value of $39.7 million for FY2024, which is 468.19% down from last year.
  • Per Rigel Pharmaceuticals' latest filing, its Change in Acquisitions & Divestments stood at $20.7 million for Q3 2025, which was up 24550.0% from $15.8 million recorded in Q2 2025.
  • Over the past 5 years, Rigel Pharmaceuticals' Change in Acquisitions & Divestments peaked at $30.8 million during Q4 2021, and registered a low of $1.4 million during Q3 2021.
  • Moreover, its 5-year median value for Change in Acquisitions & Divestments was $15.6 million (2023), whereas its average is $15.4 million.
  • Per our database at Business Quant, Rigel Pharmaceuticals' Change in Acquisitions & Divestments crashed by 9653.83% in 2021 and then surged by 200271.62% in 2022.
  • Over the past 5 years, Rigel Pharmaceuticals' Change in Acquisitions & Divestments (Quarter) stood at $30.8 million in 2021, then crashed by 31.39% to $21.2 million in 2022, then tumbled by 71.65% to $6.0 million in 2023, then rose by 12.5% to $6.8 million in 2024, then skyrocketed by 207.11% to $20.7 million in 2025.
  • Its last three reported values are $20.7 million in Q3 2025, $15.8 million for Q2 2025, and $11.1 million during Q1 2025.